TOMEEKA HAWTHORNE: Open Payments
NPI 1578076014 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,632 in 115 payments from 34 companies in 2025. Trend: 2023 $2,436 · 2024 $3,098 · 2025 $2,632
Food & beverage: $2,539Education: $93
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $322 |
| Merck Sharp & Dohme LLC | 13 | $289 |
| AstraZeneca Pharmaceuticals LP | 10 | $237 |
| Incyte Corporation | 9 | $204 |
| GlaxoSmithKline, LLC. | 4 | $138 |
| ABBVIE INC. | 5 | $127 |
| PFIZER INC. | 5 | $126 |
| Eisai Inc. | 4 | $113 |
| Daiichi Sankyo Inc. | 3 | $87 |
| ARRAY BIOPHARMA INC | 3 | $78 |
Products named: KEYTRUDA, JEMPERLI, KISQALI, IMFINZI, Lenvima, ENHERTU, SCEMBLIX, BESREMI.
Industry payments across MD — which companies pay providers there.
